The Valley Desk

NCT06890338 · Interventional trial

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Overall registry status Recruiting

Phase 2

Conditions Epithelial Ovarian Cancer, Fallopian Tube Cancer, Neoadjuvant, Primary Peritoneal Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov